Blast at pharma plant premises, 6 people died till now

Published On 2024-04-04 10:48 GMT   |   Update On 2024-04-04 10:48 GMT

Hyderabad: The toll in the explosion within a chemical reactor at a facility of pharmaceutical firm in the Telangana's Sangareddy district climbed to six, as officially confirmed by the police on Thursday.

Four individuals lost their lives, and sixteen others sustained injuries in the explosion that took place at the SB Organics Ltd's factory, situated in Chandapur village of Hathnoora mandal of the district on Wednesday.

As per the recent PTI report, the police said that the body of one worker was discovered under the wreckage in the factory premises on Thursday. Additionally, another injured individual tragically passed away while receiving treatment on Wednesday night.

The deceased include the Company's director and workers of the unit. They belong to Andhra Pradesh, Telangana, Tamil Nadu and Madhya Pradesh.

The explosion, which ignited a fire that swiftly spread throughout the pharmaceutical unit's premises, was subsequently contained, Police and Fire department officials had said.

The injured, numbering sixteen, have been shifted to various hospitals for necessary treatment.

A case has been registered against the company, as confirmed by a senior police official, with investigations underway to ascertain the cause of the explosion.

Read also: Fire at PGI's Advanced Cardiac Centre, MC directs SFO to submit report

Tags:    

Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.

NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News